Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy.
Suzuki
Kumi
K
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's, Medical University School of Medicine, 8-1 Kawadacho, Shinjukuku, Tokyo 162-8666, Japan.
Babazono
Tetsuya
T
Murata
Hidekazu
H
Iwamoto
Yasuhiko
Y
D000328:Adult; D015415:Biomarkers / Q000652:urine; D002352:Carrier Proteins / Q000652:urine*; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000652:urine*; D003928:Diabetic Nephropathies / Q000652:urine*; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids / Q000652:urine; D006801:Humans; D007676:Kidney Failure, Chronic / Q000652:urine
D015415:Biomarkers; D002352:Carrier Proteins; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids; D003404:Creatinine